Daniel Rubins is a Principal Scientist at Merck, specializing in imaging science with a focus on PET and SPECT technologies for drug development. They obtained a Ph.D. in Biomedical Physics from UCLA, where their thesis centered on atlas-based analysis methods for brain PET studies. Following a postdoctoral fellowship at Brookhaven National Laboratory, where they developed partial volume correction methods, Rubins has contributed significantly to various projects at Merck related to oncology, diabetes, neurology, and cardiovascular diseases. Their expertise includes PET image analysis techniques and kinetic modeling, and they actively present findings at internal and external conferences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices